Bristol-Myers Squibb (NYSE:BMY) traded today at a new 52-week high of $37.25. So far today approximately 5.9 million shares have been exchanged, as compared to an average 30-day volume of 9.5 million shares.
In the past 52 weeks, Bristol-Myers Squibb share prices have been bracketed by a low of $30.64 and a high of $37.25 and are now at $37.08, 21% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.9%.
Bristol-Myers Squibb (NYSE:BMY) is currently priced 3.2% above its average consensus analyst price target of $35.91. The stock should find initial support at its 50-day moving average (MA) of $34.99 and further support at its 200-day MA of $33.86.
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.